Ethyol and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ethyol (amifostine) and Neupogen (filgrastim). Common drug interactions include vomiting among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Ethyol and Neupogen. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Ethyol?

Ethyol has active ingredients of amifostine. eHealthMe is studying from 1,484 Ethyol users. Check the latest studies of Ethyol.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 18, 2026

32 people who take Ethyol and Neupogen together, and have interactions are studied.

What are the common drug interactions of Ethyol and Neupogen, by gender? *:

female:

Vomiting
White blood cell count decreased
Anaemia (lack of blood)
Burning sensation
Dehydration (dryness resulting from the removal of water)
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Discomfort
Grand mal convulsion (a type of generalized seizure that affects the entire brain)
Herpes simplex (herpes simplex is a common viral infection)

male:

Pyrexia (fever)
Fatigue (feeling of tiredness)
Diarrhoea
Hypokalaemia (low potassium)
Localised infection (infection at the single location)
Malaise (a feeling of general discomfort or uneasiness)
Pharyngolaryngeal pain
Rash generalised (rash on most of body parts)
Skin exfoliation (removal of the oldest dead skin cells)
Abdominal strangulated hernia (abdominal blood supply damaged hernia)

What are the common drug interactions of Ethyol and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Blood creatinine increased
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Diarrhoea
Glomerular filtration rate decreased
Hypotension (abnormally low blood pressure)
Implant infection (infection at implant site)
Inflammation
Labile blood pressure (wildly fluctuating blood pressure)
Oedema (fluid collection in tissue)

10-19:

n/a

20-29:

n/a

30-39:

Blood bilirubin increased
Rash pruritic (redness with itching)
Respiratory distress (difficulty in breathing)
Rigors (an episode of shaking or exaggerated shivering)

40-49:

n/a

50-59:

Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hypoaesthesia (reduced sense of touch or sensation)
Incision site erythema (redness of the skin at incision site)
Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Injection site urticaria (rash of round, red welts on the skin at injection site)
Insomnia (sleeplessness)
Lymphoedema (localized fluid retention and tissue swelling)
Nausea (feeling of having an urge to vomit)
Pain
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
Herpes simplex (herpes simplex is a common viral infection)
Hypersensitivity
Injection site reaction
Localised infection (infection at the single location)
Mycoplasma infection (bacterial infection)

What are the existing conditions these people have? *

Adverse Drug Reaction: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ethyol and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously